Chemotherapy in small bowel adenocarcinoma associated with celiac disease: a report of three cases.

IF 2 4区医学 Q3 ONCOLOGY Tumori Pub Date : 2003-03-01 DOI:10.1177/030089160308900217

Anna Cecilia Bettini, Giordano D Beretta, Pierluigi Sironi, Stefania Mosconi, Roberto Labianca

引用次数: 7

Abstract

Tumors of the small intestine are rare and usually occur in association with genetic disease and chronic intestinal inflammation. We report three cases of small bowel adenocarcinoma in patients affected by celiac disease who received a safe chemotherapy regimen (FOLFOX IV or LV5FU2) after tumor resection.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

腹腔疾病伴小肠腺癌的化疗:附3例报告

小肠肿瘤是罕见的，通常发生在遗传疾病和慢性肠道炎症。我们报告了三例腹腔疾病患者在肿瘤切除后接受安全化疗方案(FOLFOX IV或LV5FU2)的小肠腺癌病例。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Tumori 医学-肿瘤学

CiteScore

3.50

自引率

0.00%

发文量

审稿时长

6 months

期刊介绍： Tumori Journal covers all aspects of cancer science and clinical practice with a strong focus on prevention, translational medicine and clinically relevant reports. We invite the publication of randomized trials and reports on large, consecutive patient series that investigate the real impact of new techniques, drugs and devices inday-to-day clinical practice.

期刊最新文献

Efficacy and safety of hepatic arterial infusion chemotherapy followed by transarterial embolization for hepatocellular carcinoma. Prevalence of breast cancer in ovarian cancer patients and its impact on patient survival: An analysis of the surveillance, epidemiology, and end results data. Associations between vascular endothelial growth factor polymorphisms and response to 5-FU-based pharmaceutical therapy in esophageal squamous cell carcinoma: A meta-analysis. Towards a better registration of neuroendocrine neoplasms: The results of the Italian retrospective population-based study. ESCO1 as a novel predictive biomarker and potential therapeutic target in renal cell carcinoma.